Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

News

Ansell slips as results miss expectations

Trevor Chappell  |  14 Aug 2017Text size  Decrease  Increase  |  

Page 1 of 1

MELBOURNE - [AAP] Shares in Ansell (ASX: ANN) have fallen to a six-month low after the gloves and protective clothing maker's annual financial results missed market expectations.

Ansell's net profit for the year to June 30 fell 7.2 per cent to $US147.7 million ($A186.8 million), with the prior year's result partly boosted by a gain on the company's sale of its Onguard footwear-protection business.

Excluding the impact of acquisitions, divestments and exits, sales grew by 3.6 per cent in constant currency terms.

Citi Global Markets said Ansell missed analysts' consensus estimates on sales, earnings, net profit, total annual dividend, and guidance on earnings per share.

While Ansell's sales were okay, Citi said costs were up and the company is likely to incur higher costs during a transformation program to improve its manufacturing capabilities and supply chain, invest in more acquisitions, and simplify its organisational structure.

Ansell said it was considering options on how to redeploy sales proceeds from the $US600 million divestment of its condoms business to a Chinese consortium, which was announced in May.

It anticipates the sale, which is expected to generate a gain of $US365 million, will be completed by the end of September.

"Acquisition opportunities remain a focus for enhanced growth if they can meet our demanding strategic and financial criteria," Ansell said in a statement on Monday.

"We also see the opportunity to increase investment in our existing business as outlined in the transformation program."

Ansell also expects to redeploy some of the sale proceeds to its current $US265 million share buyback.

The company expects basic earnings per share from its continuing businesses of 91 US cents to $US1.01 in 2017/18.

The guidance excludes an expected 1-to-2 US cents contribution from the condoms business; the benefits from the share buyback; the gain on the sale of the condoms business; and $30 million in transformation costs.

Shares in Ansell were 67 cents, or 3.1 per cent, lower at $20.75 at 1200 AEST.

ANSELL RESULTS MISS EXPECTATIONS

* Annual profit down 7.2pct to $US147.7m

* Revenue up 1.7 per cent higher at $US1.6bn

* Final dividend up 0.25 US cents to 23.75 US cents, unfranked

 

AAP logo image

© [2017] Australian Associated Press Pty Limited (AAP) or its Licensors. This is the Morningstar service with content provided by AAP where indicated. AAP reserves all rights, including copyright, in services provided by it. The information in the service is for personal use only, does not constitute financial product advice (whether general or personal) and may not be re-written, copied, re-sold or re-distributed, framed, linked or otherwise used whether for compensation of any kind or not, without the prior written permission of AAP. You should seek advice from a professional financial adviser before making decision to acquire or dispose of a financial product.

This service is published for general information purposes only without assuming a duty of care. AAP is not in the business of providing financial product advice (whether personal or general advice), and gives no warranty, guarantee or other representation about the accuracy of the information or images contained in this service. AAP is not liable for errors, omissions in, delays or interruptions to or cessation of the services through negligence or otherwise. The globe symbol and "AAP" are registered trademarks.